Abciximab and Excessive Bleeding in Patients Undergoing Emergency Cardiac Operations

This publication has 13 references indexed in Scilit:

• In Vitro Effects of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist c7E3 Fab on the Activated Clotting Time
  Circulation, 1997
• Hemorrhage and the Use of Blood Products After Adult Cardiac Operations: Myths and Realities
  The Annals of Thoracic Surgery, 1996
• Role of Platelets in Restenosis After Percutaneous Coronary Revascularization
  Journal of the American College of Cardiology, 1996
• EPILOG and CAPTURE Trials Halted Because of Positive Interim Results
  Circulation, 1996
• Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention
  Circulation, 1995
• Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)
  The American Journal of Cardiology, 1995
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Inhibitors of the platelet glycoprotein IIb/IIIa receptor as conjunctive therapy for coronary artery thromboiysis
  Coronary Artery Disease, 1992
• Monoclonal Antibodies to Platelet Glycoprotein IIb/IIIa as Antithrombotic Agentsa
  Annals of the New York Academy of Sciences, 1991
• A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
  Journal of Clinical Investigation, 1985